Columnist Betty Vertin hopes her family's experience with kidney stones might help you be better prepared while living with DMD.
The FDA has given the green light to a clinical trial testing ATA-200, a gene therapy for limb-girdle muscular dystrophy ...
Sarepta has stopped developing SRP-5051, its exon 51-skipping therapy for Duchenne MD, due to long-term safety concerns and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback